- Home
- CMMB vs RMCF Comparison
CMMB vs RMCF Comparison
Compare CMMB & RMCF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMMB
- RMCF
- Stock Information
- Founded
- CMMB 2004
- RMCF 1981
- Country
- CMMB Israel
- RMCF United States
- Employees
- CMMB N/A
- RMCF N/A
- Industry
- CMMB Biotechnology: Pharmaceutical Preparations
- RMCF Specialty Foods
- Sector
- CMMB Health Care
- RMCF Consumer Staples
- Exchange
- CMMB Nasdaq
- RMCF Nasdaq
- Market Cap
- CMMB 13.7M
- RMCF 11.4M
- IPO Year
- CMMB N/A
- RMCF N/A
- Fundamental
- Price
- CMMB $3.28
- RMCF $1.51
- Analyst Decision
- CMMB Strong Buy
- RMCF
- Analyst Count
- CMMB 2
- RMCF 0
- Target Price
- CMMB $26.50
- RMCF N/A
- AVG Volume (30 Days)
- CMMB 260.4K
- RMCF 182.7K
- Earning Date
- CMMB 11-13-2025
- RMCF 10-13-2025
- Dividend Yield
- CMMB N/A
- RMCF N/A
- EPS Growth
- CMMB N/A
- RMCF N/A
- EPS
- CMMB N/A
- RMCF N/A
- Revenue
- CMMB N/A
- RMCF $29,988,000.00
- Revenue This Year
- CMMB N/A
- RMCF N/A
- Revenue Next Year
- CMMB N/A
- RMCF N/A
- P/E Ratio
- CMMB N/A
- RMCF N/A
- Revenue Growth
- CMMB N/A
- RMCF 8.09
- 52 Week Low
- CMMB $2.39
- RMCF $1.12
- 52 Week High
- CMMB $9.84
- RMCF $3.49
- Technical
- Relative Strength Index (RSI)
- CMMB 59.76
- RMCF 42.93
- Support Level
- CMMB $3.03
- RMCF $1.51
- Resistance Level
- CMMB $3.50
- RMCF $1.75
- Average True Range (ATR)
- CMMB 0.21
- RMCF 0.13
- MACD
- CMMB 0.02
- RMCF -0.02
- Stochastic Oscillator
- CMMB 64.21
- RMCF 5.13
About CMMB Chemomab Therapeutics Ltd.
Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin, and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life-threatening fibrotic and inflammatory diseases. It is advancing three Phase 2 clinical trials in parallel for CM-101, treating rare fibrotic conditions.
About RMCF Rocky Mountain Chocolate Factory Inc.
Rocky Mountain Chocolate Factory Inc operates as a manufacturer of chocolate candies and confectionery products. The business activity of the firm functions through Franchising, Manufacturing, Retail Stores, U-Swirl Operations, and Other t. The products of the company include varieties of Clusters, Caramels, Creams, Toffees, Mints, and Truffles.